Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Aishwarya Rai Bachchan's look continues to be a topic of discussion at the Cannes 2024 Internatio
Following the car bombing near the Red Fort in Delhi and the recovery of explosives from Faridaba
After Natasha Stankovic and Hardik Pandya, another cricketer's married life has been shaken. Indi
Congress MP Shashi Tharoor, who is facing criticism from his own party leaders, has hit back and
IND vs WI: KL Rahul celebrates in a new style, dedicates Test century to a special person
KL Rahul ended a 3,211-day wait for a Test century on home soil. After scoring a century on the s
BSF Constable Returns: Pakistan bows down to India, hands over BSF Jawan Purnam Kumar
BSF jawan Purnam Kumar Shaw, posted in Ferozepur sector of Punjab, had inadvertently crossed the
The people of Delhi-NCR have been getting relief from the humid heat for the last three days. The
After Deepika Padukone's exit from Sandeep Reddy Vanga's film 'Spirit', Sandeep Reddy Vanga made
There was a strong dust storm in Mumbai on Monday along with the first rain o
India has done wonders again with the SpadeX mission. The 44.5-meter-long Polar Satellite Launch
